Aspivix in the News


Aspivix et Venture kick 15/12/2017

Four new startups pass Venture Kick stage 1

Every year, 65 million obstetric and gynaecological treatments require access to the uterus. The standard use of Tenaculum forceps may be painful as well as traumatic and pose a risk of cross-contamination...

Lire la suite

EVC finalists 10/10/2017

Congrats! @Monito @SWISSto12 #Aspivix #Comphya selected as EVC finalists #AHVF17 | Good luck for finals in December in Duesseldorf!

Lire la suite

EPFL Innovation Park 22/02/2017

The startup has developed “ASPIVIX”, a single-use simple suction pad technology for tenaculum to minimise pain for the women during the gynecologist’s visit...

Lire la suite

Startup Ticker 04/01/2017

Nominees for the Pionierpreis 2017 are…

Aspivix SA is a Medtech start-up developing medical instruments to innovate women’s healthcare. The startup has developed a medical device “ASPIVIX”, a new and simple suction pad technology for tenaculum, to turn painful and traumatic common gynaecological practices into gentle ones...

Lire la suite

L’alternative à la pince de Pozzi 18/05/2015

ASPIVIX. La start-up lausannoise développe un instrument pour les actes médicaux les plus courants en gynécologie.

Une start-up lausannoise recherche des investisseurs pour lancer un instrument gynécologique offrant une alternative sans danger pour les actes médicaux les plus courants. Le marché est estimé à 400 millions de francs par an, avec une demande chinoise potentiellement élevée.

Lire la suite